Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2013, Vol. 18 ›› Issue (7): 769-773.

Previous Articles     Next Articles

Study of the effects and the mechanism of resveratrol on platelet aggregation in hyperlipidemia rats

BAI Yun-xia   

  1. Hangzhou First Hospital, Hangzhou 310000,Zhejiang,China
  • Received:2012-11-19 Revised:2013-05-25 Online:2013-07-26 Published:2013-06-20

Abstract: AIM: To explore the effects and the mechanism of resveratrol on platelet aggregation in hyperlipidemia rats.METHODS: Experimental hyperlipidemia rats were ig administrated of resveratrol (50 mg·kg-1·d-1) or vehicle for 30 d. The levels of TC, TG, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), malondialdehyde (MDA), superoxide dismutase (SOD), NO, endothelial nitric oxide synthase (eNOS), granulemembrane protein-140(GMP-140),thromboxaneB2 (TXB2),6-keto -prostaglandin F (6-keto-PGF) and platelet maximal aggregation rate(MAR)which was induced by ADP in 5 minute were measured.RESULTS: Compared with the high fat diet (HFD) group, the levels of TG, TC,LDL-C were decreased respectively by 19%, 31%,51% and the level of HDL-C increased in 1.33 folds after the rats fed and ig resveratrol (50 mg·kg-1·d-1) for 30 d. The activities of SOD and eNOS and the content of NO and 6-keto-PGF in resveratrol group were increased (P<0.01).And the contents of MDA, GMP-140,TXB2 and MAR in resveratrol group were decreased (P<0.05).CONCLUSION: Platelet aggregation rate was decreased in experimental hyperlipidemia rats by i.g. administration of resveratrol, its mechanism closely correlates with decline of plasma lipid and with anti- peroxide of lipid , protecting vaso endothelial cells , improving the synthesis of NO , keeping the balance of TXA2 and PGI2 in tissue or plasma and the balance between extracellular calcium and intracellular calcium.

Key words: Resveratrol, Hyperlipidemia, Platelet aggregation

CLC Number: